000			01436 a2200361 4500
005			20250512063813.0
264		0	_c19871030
008			198710s 0 0 eng d
022			_a0014-4835
024	7		_a10.1016/s0014-4835(87)80045-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aBito, L Z
245	0	0	_aEicosanoids as a new class of ocular hypotensive agents. 1. The apparent therapeutic advantages of derived prostaglandins of the A and B type as compared with primary prostaglandins of the E, F and D type. _h[electronic resource]
260			_bExperimental eye research _cJun 1987
300			_a825-37 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Topical
650	0	4	_aAnimals
650	0	4	_aCats
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHyperemia _xchemically induced
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aOcular Hypertension _xdrug therapy
650	0	4	_aProstaglandins _xadverse effects
650	0	4	_aProstaglandins A _xadministration & dosage
650	0	4	_aProstaglandins B _xadministration & dosage
650	0	4	_aRabbits
700	1		_aBaroody, R A
700	1		_aMiranda, O C
773	0		_tExperimental eye research _gvol. 44 _gno. 6 _gp. 825-37
856	4	0	_uhttps://doi.org/10.1016/s0014-4835(87)80045-3 _zAvailable from publisher's website
999			_c3658979 _d3658979